Veracyte (NASDAQ: VCYT) reported Q1 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $67.8 million versus the consensus estimate of $62.32 million.

GUIDANCE:

Veracyte sees FY2022 revenue of $265-275 million, versus the consensus of $270 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.